Advanced search
Publication Cover
Expert Review of Hematology Volume 6, 2013 - Issue 2
Submit an article Journal homepage
1,210
Views
16
CrossRef citations to date
0
Altmetric
Review

The current status and future impact of targeted therapies in non-Hodgkin lymphoma

Chaitra Ujjani Georgetown University, 3800 Reservoir Rd. NW, Washington, DC 20007, USA. [email protected]
&
Bruce D Cheson Georgetown University, 3800 Reservoir Rd. NW, Washington, DC 20007, USA
Pages 191-203 | Published online: 10 Jan 2014

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Sylvain Garciaz, Diane Coso, Jean-Marc Schiano de Colella & Réda Bouabdallah. (2016) Lenalidomide for the treatment of B-cell lymphoma. Expert Opinion on Investigational Drugs 25:9, pages 1103-1116.
Read now
Hua-Fei Li, Cong Wu, Ting Chen, Ge Zhang, He Zhao, Chang-Hong Ke & Zheng Xu. (2015) Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity. International Journal of Nanomedicine 10, pages 4783-4796.
Read now
Susanne Liewer & Ashley N Huddleston. (2015) Oral targeted therapies: managing drug interactions, enhancing adherence and optimizing medication safety in lymphoma patients. Expert Review of Anticancer Therapy 15:4, pages 453-464.
Read now

Articles from other publishers (13)

Rossana Percario, Paolo Panaccio, Fabio F. Mola, Pierluigi Di Sebastiano & Tommaso Grottola. 2021. Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Clinical Pancreatology for Practising Gastroenterologists and Surgeons 641 649 .
Ling Zhang, Pukhraz Basra & Serhan Alkan. 2020. Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver. Diagnostic Pathology of Hematopoietic Disorders of Spleen and Liver 11 35 .
Libin Zhang, Yixin Fang, Lian Li, Jiyuan Yang, D. Christopher Radford & Jindřich Kopeček. (2018) Human Serum Albumin‐Based Drug‐Free Macromolecular Therapeutics: Apoptosis Induction by Coiled‐Coil‐Mediated Cross‐Linking of CD20 Antigens on Lymphoma B Cell Surface. Macromolecular Bioscience 18:11, pages 1800224.
Crossref
Lian Li, Jiyuan Yang, Jiawei Wang & Jindřich Kopeček. (2018) Amplification of CD20 Cross-Linking in Rituximab-Resistant B-Lymphoma Cells Enhances Apoptosis Induction by Drug-Free Macromolecular Therapeutics. ACS Nano 12:4, pages 3658-3670.
Crossref
Aradhana Awasthi, Delphine C.M. Rolland, Janet Ayello, Carmella van de Ven, Venkatesha Basrur, Kevin Conlon, Damian Fermin, Matthew J. Barth, Christian Klein, Kojo S.J. Elenitoba-Johnson, Megan S. Lim & Mitchell S. Cairo. (2017) A comparative global phosphoproteomics analysis of obinutuzumab (GA101) versus rituximab (RTX) against RTX sensitive and resistant Burkitt lymphoma (BL) demonstrates differential phosphorylation of signaling pathway proteins after treatment. Oncotarget 8:69, pages 113895-113909.
Crossref
Simone M. Goldinger, Emmanuella Guenova, Kazuyasu Fujii & Mirjana Urosevic-Maiwald. 2016. Immunology of the Skin. Immunology of the Skin 463 475 .
Aradhana Awasthi, Janet Ayello, Carmella Van de Ven, Mona Elmacken, Anthony Sabulski, Matthew J. Barth, Myron S. Czuczman, Humayun Islam, Christian Klein & Mitchell S. Cairo. (2015) Obinutuzumab (GA101) compared to rituximab significantly enhances cell death and antibody-dependent cytotoxicity and improves overall survival against CD20+ rituximab-sensitive/-resistant Burkitt lymphoma (BL) and precursor B-acute lymphoblastic leukaemia. British Journal of Haematology 171:5, pages 763-775.
Crossref
John G. GribbenNathan FowlerFranck Morschhauser. (2015) Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma. Journal of Clinical Oncology 33:25, pages 2803-2811.
Crossref
Sarah A. Johnson, Anita Kumar, Matthew J. Matasar, Heiko Schöder & Jürgen Rademaker. (2015) Imaging for Staging and Response Assessment in Lymphoma. Radiology 276:2, pages 323-338.
Crossref
Xiaojun YuMarta IleckaEmmalene J. BartlettViktor SchneidtRauf BhatJosef Mautner, Regina FeederleHenri-Jacques Delecluse. (2015) Antigen-armed antibodies targeting B lymphoma cells effectively activate antigen-specific CD4+ T cells. Blood 125:10, pages 1601-1610.
Crossref
Kumar Sandrasegaran, Anderanik Tomasian, Khaled M. Elsayes, Harris Nageswaran, Akram Shaaban, Alampady Shanbhogue & Christine O. Menias. (2014) Hematologic malignancies of the pancreas. Abdominal Imaging 40:2, pages 411-423.
Crossref
Brandon G. Smaglo, Dalal Aldeghaither & Louis M. Weiner. (2014) The development of immunoconjugates for targeted cancer therapy. Nature Reviews Clinical Oncology 11:11, pages 637-648.
Crossref
Emmanuel Bachy & Bertrand Coiffier. (2014) Anti-PD1 antibody: a new approach to treatment of lymphomas. The Lancet Oncology 15:1, pages 7-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.